SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K/A - Current report: [Amend]
SEC Accession No. 0001104659-14-017128
Filing Date
2014-03-06
Accepted
2014-03-06 17:06:16
Documents
4
Period of Report
2014-03-03
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K/A a14-7412_18ka.htm 8-K/A 30026
2 EX-10.1 a14-7412_1ex10d1.htm EX-10.1 88972
3 EX-10.2 a14-7412_1ex10d2.htm EX-10.2 81936
4 EX-10.3 a14-7412_1ex10d3.htm EX-10.3 116377
  Complete submission text file 0001104659-14-017128.txt   318500
Mailing Address 901 GATEWAY BLVD S. SAN FRANCISCO CA 94080
Business Address 901 GATEWAY BLVD SOUTH SAN FRANCISCO CA 94080 6508086000
THERAVANCE INC (Filer) CIK: 0001080014 (see all company filings)

IRS No.: 943265960 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K/A | Act: 34 | File No.: 000-30319 | Film No.: 14673846
SIC: 2834 Pharmaceutical Preparations